|
|
||||||||
Departments of Medicine and Radiology, Duke University Medical Center
The Durham VA Medical Center, Durham, North Carolina
Correspondence: For reprints contact: Jerome M. Feldman, MD, Box 2963, Duke University Med. Ctr., Durham, NC 27710.
ABSTRACT
Iodine-131 metaiodobenzylguanidine ([131I]MIBG)is concentrated in pheochromocytomas and can be detected by external imaging. We administered [131I]MIBG to 23 patients with carcinoid tumors to determine if it would be useful in scanning patients with these tumors. The carcinoid tumors of 14 of the 23 patients (61%) were visualized. Iodine-131 MIBG was concentrated most avidly by tumors of midgut origin (ileum, cecum); it was concentrated less avidly by some tumors of foregut origin (pancreas, stomach); it was not significantly concentrated by other tumors of foregut origin (bronchus). We conclude that 131I is a useful imaging agent for carcinoid tumors.
This article has been cited by other articles:
![]() |
S. Hoegerle, C. Altehoefer, N. Ghanem, G. Koehler, C. F. Waller, H. Scheruebl, E. Moser, and E. Nitzsche Whole-Body 18F Dopa PET for Detection of Gastrolintestinal Carcinoid Tumors Radiology, August 1, 2001; 220(2): 373 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rainis, S. Ben-Haim, and G. Dickstein False Positive Metaiodobenzylguanidine Scan in a Patient with a Huge Adrenocortical Carcinoma J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 5 - 7. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |